1. Home
  2. CHPT vs CCCC Comparison

CHPT vs CCCC Comparison

Compare CHPT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHPT
  • CCCC
  • Stock Information
  • Founded
  • CHPT 2007
  • CCCC 2015
  • Country
  • CHPT United States
  • CCCC United States
  • Employees
  • CHPT N/A
  • CCCC N/A
  • Industry
  • CHPT Industrial Specialties
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHPT Consumer Discretionary
  • CCCC Health Care
  • Exchange
  • CHPT Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • CHPT 340.1M
  • CCCC 104.4M
  • IPO Year
  • CHPT N/A
  • CCCC 2020
  • Fundamental
  • Price
  • CHPT $0.66
  • CCCC $2.26
  • Analyst Decision
  • CHPT Hold
  • CCCC Buy
  • Analyst Count
  • CHPT 10
  • CCCC 3
  • Target Price
  • CHPT $1.46
  • CCCC $12.00
  • AVG Volume (30 Days)
  • CHPT 17.8M
  • CCCC 1.6M
  • Earning Date
  • CHPT 09-03-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • CHPT N/A
  • CCCC N/A
  • EPS Growth
  • CHPT N/A
  • CCCC N/A
  • EPS
  • CHPT N/A
  • CCCC N/A
  • Revenue
  • CHPT $407,681,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • CHPT $3.54
  • CCCC N/A
  • Revenue Next Year
  • CHPT $26.21
  • CCCC N/A
  • P/E Ratio
  • CHPT N/A
  • CCCC N/A
  • Revenue Growth
  • CHPT N/A
  • CCCC 98.56
  • 52 Week Low
  • CHPT $0.51
  • CCCC $1.09
  • 52 Week High
  • CHPT $2.44
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CHPT 39.96
  • CCCC 63.62
  • Support Level
  • CHPT $0.67
  • CCCC $1.36
  • Resistance Level
  • CHPT $0.73
  • CCCC $2.17
  • Average True Range (ATR)
  • CHPT 0.05
  • CCCC 0.15
  • MACD
  • CHPT -0.01
  • CCCC 0.05
  • Stochastic Oscillator
  • CHPT 0.47
  • CCCC 67.11

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: